BPA Call VA25017A0009-VA25017J2113
Award Date 2/28/17
Potential Completion Date 4/15/17
Potential Value $106K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Deerfield, IL 60015, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) schedule contract, awarded by the Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company. The award, valued at $217,000.00, is for the supply of 1,200 vials of the drug GLASSIA (alpha 1-proteinase inhibitor human, 1 gram/50 milliliters) for the VA's fiscal year 2016 requirements. The contract has a period of performance ending on September 30, 2016 and...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price Blanket Purchase Agreement (BPA) call order to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, to provide the GLASSIA medicine. The contract, valued at $118,800.00, was awarded under the GSA Pharmaceuticals and Drugs schedule contract and does not have a set-aside designation. Baxalta is a provider of specialty pharmaceuticals, including products for the treatment of bleeding...
- This is a federal contract award to Baxalta US Inc., a foreign-owned for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract, valued at $78,439.06, is for the delivery of GAMMAGARD, a pharmaceutical product, through the VA's Veterans Integrated Service Network 23. The contract was awarded under the General Services Administration's (GSA) Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has a firm fixed-price pricing type. The contract...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, under the GSA Pharmaceuticals and Drugs schedule contract. The contract is for the provision of BLOOD PRODUCT with a ceiling value of $113,835.30 and a period of performance ending on December 15, 2016. The contract was awarded on December 15, 2016 and was not set aside for any specific business type. Baxalta US Inc....
- This is a delivery order contract awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company. The contract is for the supply of GAMMAGARD 10% immune globulin infusion, a specialty medication used to treat immunodeficiencies and other rare chronic conditions. The contract has a ceiling value of $86,347.03 and covers the period from October 1, 2015, to September 30, 2016. The...
- This is a delivery order issued by the Veterans Integrated Service Network 7 (VISN 7) of the U.S. Department of Veterans Affairs to the prime contractor Baxalta US Inc. The order is for FEIDA DRUG, which is likely a pharmaceutical product. The contract is awarded under Baxalta's General Services Administration (GSA) Pharmaceuticals and Drugs schedule contract and has a firm fixed price of $187,137.60. The contract has an ultimate completion date of November 7, 2016. Baxalta US Inc. is a...
- This is a delivery order contract awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned for-profit pharmaceutical company. The contract is for the provision of FEIBA, a pharmaceutical product, to the VA system. The contract has a ceiling value of $89,821.60 and was awarded on October 5, 2018, with a period of performance ending on September 30, 2019. The contract was placed against Baxalta's existing...
- This federal contract award is for the delivery of ADVATE, a specialty pharmaceutical product, to the Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth. The prime contractor is Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company that provides drugs and biologics to government agencies through its GSA Pharmaceuticals and Drugs schedule contract. The contract is a $150,000.00 firm fixed-price delivery order with an April 1, 2020 award and...
- This federal contract award is for the procurement of pharmaceutical products, specifically immune globulin medications, by the U.S. Department of Veterans Affairs (VA). The contract was awarded to CSL Behring L.L.C., a global biotherapeutics company, under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has a ceiling value of $102,089.00 and is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The contract is...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 awarded a Blanket Purchase Agreement (BPA) call to Shire US Inc., a foreign-owned, for-profit manufacturer of goods, for the express order of pharmaceuticals for May 2017 in fiscal year 2017. The contract, which was not set aside, has a firm fixed price of $104,243.40 and a completion date of May 31, 2017. The contract was awarded on May 1, 2017 under the Pharmaceuticals and Drugs Federal...